| Financial Year |
March 31 2023 |
| Monetary Funds |
145,298,392.26 |
| Held-for-trading Financial Assets |
5,217,177.42 |
| Notes Receivable |
7,343,924.70 |
| Accounts Receivable |
147,997,115.97 |
| Advances to Suppliers |
37,339,857.40 |
| Other Receivables |
1,712,522.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
351,171,448.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
273,052,128.21 |
| Total Current Assets |
969,645,137.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
185,074,446.62 |
| Under-construction Projects |
29,283,596.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,833,277.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,131,488.60 |
| Deferred Income Tax Assets |
1,231,419.67 |
| Other Non-Current Assets |
19,335,474.00 |
| Sub-Total of Non-Current Assets |
257,716,589.88 |
| Total Assets |
1,227,361,727.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
202,315,310.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,782,581.68 |
| Taxes Payable |
2,990,959.56 |
| Interest Payable |
-- |
| Dividend Payable |
40,399,180.00 |
| Other payables |
40,872,253.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,190,005.66 |
| Other Current Liabilities |
126,543.09 |
| Sub-Total of Current Liabilities |
256,595,930.51 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
482,416.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,104,720.53 |
| Total Liabilities |
279,700,651.04 |
| Paid-In Capital(Or Share Stock) |
164,340,000.00 |
| Capital Surplus |
363,756,063.68 |
| Surplus Reserve |
66,220,800.80 |
| LESS:Treasury Stock |
24,462,273.21 |
| Undistributed Profits |
351,489,261.63 |
| Minority Stockholder's Interest |
26,317,223.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
921,343,852.90 |
| Owner's Equity（Stockholder's Equity） |
947,661,075.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,227,361,727.00 |
